PET/CT can predict therapy response in some lymphomas
A Johns Hopkins University study added to the growing base of evidence showing that quantitative PET/CT can predict the response to treatment in patients with bone metastases from lymphomas.
Dr. Behnaz Goudarzi and colleagues retrospectively reviewed PET/CT reports from 1100 patients with lymphoma. They identified a subset of 28 patients with aggressive lymphoma and bone lesions with high FDG uptake and compared standardized uptake values and Hounsfield unit values for these lesions before and after therapy. Evidence of treatment response came in the form of significant decrease in FDG uptake and increase in tumor density. They presented their findings at the 2007 RSNA meeting .
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.